Category Archives: TB

XDR-TB treatment outcomes are dismal, spell trouble for global public health

By on .

“The situation regarding MDR and XDR tuberculosis is bleak,” according to a commentary in response to a study looking at long-term outcomes of extensively drug-resistant tuberculosis patients in South Africa, published in The Lancet last week by Elize Pietersen and colleagues. Researchers followed up with South African patients with XDR-TB who had been a part […]

USAID details TB work, results, continuing challenges in “Impact and Leadership” for 2013

By on .

By the time Azmara Ashenafi’s multidrug-resistant tuberculosis was diagnosed, she had been wasting away, coughing and running fevers for three years. She had been on ineffective treatment for six months. Her three-year-old son had drug-resistant TB as well. The story of the young Ethiopian mother is highlighted in USAID’s Fiscal Year 2013 report, Impact and […]

To address TB, address social causes, say Pan-American health leaders

By on .

When Dr. Jarbas Barbosa’s father practiced in Brazil decades ago, patients begged him to diagnose them with cancer, rather than tuberculosis. Back then,TB was worse than cancer. Now, Brazil is one of many countries in the Americas that have reached the Millennium Development goal of halving TB incidence, ahead of schedule. Barbosa, who is the […]

Tuberculosis control needs a complete and patient-centric solution

By on .

The following is a guest post by Madhukar Pai of the McGill International TB Centre, Prashant Yadav of Montreal & Stephen M. Ross School of Business, and Ravi Anupindi of the University of Michigan, Ann Arbor. Whether it is mobile phone service or vacation travel, good businesses know that success depends on providing a complete and customer-centric solution. Should patients with tuberculosis […]

TB budget cuts proposed as U.S. plans improved global disease responses

By on .

“It is possible,” Dr. William Foege told an audience this morning, “To plan a rational future.” Foege, a former Centers for Disease Control and Prevention director credited with heading the strategy that eradicated smallpox, was speaking to a gathering of CDC country post leaders planning to improve disease responses worldwide. He remembered earlier days in […]

Integrated TB and HIV treatment adds up to increased survival, improved efficiencies, and new funding focus

By on .

Around much of the world where rates of HIV-tuberculosis co-infection are highest, one of the challenges killing patients has been the wait to discover if their TB would respond to the most common treatments. A four-year South Africa study of co-infected patients showed starting treatment for HIV during the course of anti-tuberculosis treatment, rather than […]

TB study cites urgent need for new treatments, while more emerges on big pharma campaign to cite threat to “continued investment”

By on .

Examining rising rates of drug resistance accompanied by high rates of mortality that take a toll on the country’s most productive members, a Lancet article published online Friday highlights an imperative need for new drug treatments, along with more effective use of resources and policy to limit the spread of disease, The article, Long-term outcomes […]

Tuberculosis drug maker Sanofi drops price, easing access to shortened TB infection treatment

By on .

It was Christmas come early for publicly funded TB programs and for advocates of improved tuberculosis regimens when the maker of a rifapentine, a drug that can shorten treatment for tuberculosis infection from as much as nine months to three months announced Thursday it will drop its price for the medicine to a dollar a […]